Editors' ChoiceCancer Beyond molecular profiling for “precision oncology” Frank J. AttenelloDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Email: attenell{at}usc.edu See allHide authors and affiliations Science Translational Medicine 24 Oct 2018:Vol. 10, Issue 464, eaav3891DOI: 10.1126/scitranslmed.aav3891 Frank J. Attenello Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: attenell@usc.edu Article Info & Metrics eLetters Article Information vol. 10 no. 464 DOI: https://doi.org/10.1126/scitranslmed.aav3891 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: . Copyright & Usage: Copyright © 2018, American Association for the Advancement of Science Author Information Frank J. AttenelloDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Email: attenell{at}usc.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: October 2018 to January 2021 AbstractFullPdf Oct 2018034830 Nov 201803930 Dec 201801590 Jan 201941420 Feb 2019111170 Mar 201921900 Apr 201911710 May 201953615 Jun 201942821 Jul 201942210 Aug 201912690 Sep 201912601 Oct 201942630 Nov 201921912 Dec 201931090 Jan 20202420 Feb 20204410 Mar 20204260 Apr 202033360 May 20203120 Jun 20200270 Jul 20201500 Aug 20204260 Sep 20202300 Oct 20201310 Nov 20202250 Dec 20206320 Jan 2021180 View Full Text
Beyond molecular profiling for “precision oncology” By Frank J. Attenello Science Translational Medicine24 Oct 2018 Patient-derived tumor cultures genetically mirror patient tumors, expanding insights into therapeutic resistance.
Beyond molecular profiling for “precision oncology” By Frank J. Attenello Science Translational Medicine24 Oct 2018 Patient-derived tumor cultures genetically mirror patient tumors, expanding insights into therapeutic resistance.